Skip to main content
SpringerLink
Log in

Amplatzer Cardiac Plug and Amulet

  • Chapter
Left Atrial Appendage Closure

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 1036 Accesses

Abstract

The approach of percutaneous left atrial appendage (LAA) closure for stroke prevention in patients with atrial fibrillation (AF) has rapidly advanced over the past two decades. Numerous devices are under clinical investigations and several are already CE-marked. The Amplatzer Cardiac Plug (ACP) is the third commercial device manufactured specifically for endovascular LAA closure, and real-world experience to-date has shown good safety and clinical efficacy. The second-generation ACP device, Amulet, has just been re-launched. This paper reviews in-depth the device characteristics and procedural techniques of the ACP and Amulet devices.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119–25.

    Article  PubMed  Google Scholar 

  2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham study. Arch Intern Med. 1987;147:1561–4.

    Article  CAS  PubMed  Google Scholar 

  3. Lin HJ, Wolf PA, Kelly-Hayes M, et al. Stroke severity in atrial fibrillation. The Framingham study. Stroke. 1996;27:1760–4.

    Article  CAS  PubMed  Google Scholar 

  4. Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham study. Stroke. 1991;22:312–8.

    Article  CAS  PubMed  Google Scholar 

  5. Lamassa M, Di Carlo A, Pracucci G, et al. Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project). Stroke. 2001;32:392–8.

    Article  CAS  PubMed  Google Scholar 

  6. Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med. 1999;131:927–34.

    Article  CAS  PubMed  Google Scholar 

  7. Kakkar AK, Mueller I, Bassand JP, et al. Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry. PLoS One. 2013;8:e63479.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33:2719–47.

    Article  PubMed  Google Scholar 

  9. Tzikas A. LAAO for stroke prevention in AF: multicenter experience with the Amplatzer cardiac plug. Transcatheter cardiovascular therapeutics—San Francisco; 2013.

    Google Scholar 

  10. Meier B, Palacios I, Windecker S, et al. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv. 2003;60:417–22.

    Article  PubMed  Google Scholar 

  11. Nietlispach F, Gloekler S, Krause R, et al. Amplatzer left atrial appendage occlusion: single center 10-year experience. Catheter Cardiovasc Interv. 2013;82:283–9.

    Article  PubMed  Google Scholar 

  12. Freixa X, Chan JL, Tzikas A, Garceau P, Basmadjian A, Ibrahim R. The Amplatzer cardiac plug 2 for left atrial appendage occlusion: novel features and first-in-man experience. EuroIntervention. 2013;8:1094–8.

    Article  PubMed  Google Scholar 

  13. Romero J, Husain SA, Kelesidis I, Sanz J, Medina HM, Garcia MJ. Detection of left atrial appendage thrombus by cardiac computed tomography in patients with atrial fibrillation: a meta-analysis. Circ Cardiovasc Imaging. 2013;6:185–94.

    Article  PubMed  Google Scholar 

  14. Saw J, DeJong PM, Lempereur M, et al. Cardiac CT angiography follow-up of left atrial appendage closure with the Amplatzer cardiac plug. Catheter Cardiovasc Interv. 2014;83:S91.

    Google Scholar 

  15. Park JW, Bethencourt A, Sievert H, et al. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv. 2011;77:700–6.

    Article  PubMed  Google Scholar 

  16. Lam YY, Yip GW, Yu CM, et al. Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheter Cardiovasc Interv. 2012;79:794–800.

    Article  PubMed  Google Scholar 

  17. Damonte A, Costantini C, Pedra C, et al. Percutaneous closure of the left atrial appendage: initial experience in Latin America. J Am Coll Cardiol. 2013;62:B211.

    Article  Google Scholar 

  18. Lopez-Minguez JR, Eldoayen-Gragera J, Gonzalez-Fernandez R, et al. Immediate and one-year results in 35 consecutive patients after closure of left atrial appendage with the Amplatzer cardiac plug. Rev Esp Cardiol. 2013;66:90–7.

    Article  PubMed  Google Scholar 

  19. Streb W, Szymala M, Kukulski T, et al. Percutaneous closure of the left atrial appendage using the Amplatzer cardiac plug in patients with atrial fibrillation: evaluation of safety and feasibility. Kardiol Pol. 2013;71:8–16.

    PubMed  Google Scholar 

  20. Guerios EE, Schmid M, Gloekler S, et al. Left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation. Arq Bras Cardiol. 2012;98:528–36.

    Article  PubMed  Google Scholar 

  21. Urena M, Rodes-Cabau J, Freixa X, et al. Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy. J Am Coll Cardiol. 2013;62:96–102.

    Article  PubMed  Google Scholar 

  22. Meerkin D, Butnaru A, Dratva D, Bertrand OF, Tzivoni D. Early safety of the Amplatzer cardiac plug for left atrial appendage occlusion. Int J Cardiol. 2013;168:3920–5.

    Article  PubMed  Google Scholar 

  23. Park JW, Sievert H, Schillinger W, et al. Results of the Amplatzer cardiac plug European multicenter prospective observational study. J Am Coll Cardiol. 2012;60.

    Google Scholar 

  24. Viles-Gonzalez JF, Kar S, Douglas P, et al. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation) substudy. J Am Coll Cardiol. 2012;59:923–9.

    Article  PubMed  Google Scholar 

  25. Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the Watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry. Circulation. 2011;123:417–24.

    Article  PubMed  Google Scholar 

  26. Reddy VY, Mobius-Winkler S, Miller MA, et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA plavix feasibility study with watchman left atrial appendage closure technology). J Am Coll Cardiol. 2013;61:2551–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vancouver General Hospital, University of British Columbia, 2775 Laurel Street, Level 9, Vancouver, BC, Canada, V5Z1M9

    Jacqueline Saw MD, FRCPC, FACC, FSCAI

Authors
  1. Jacqueline Saw MD, FRCPC, FACC, FSCAI
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jacqueline Saw MD, FRCPC, FACC, FSCAI .

Editor information

Editors and Affiliations

  1. Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada

    Jacqueline Saw

  2. Cardiovascular Intervention Center Research, Cedars-Sinai Medical Center, Los Angeles, California, USA

    Saibal Kar

  3. Scripps Translational Science Institute, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California, USA

    Matthew J. Price

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Saw, J. (2016). Amplatzer Cardiac Plug and Amulet. In: Saw, J., Kar, S., Price, M. (eds) Left Atrial Appendage Closure. Contemporary Cardiology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-16280-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-16280-5_12

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-16279-9

  • Online ISBN: 978-3-319-16280-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation